Clinical experts across the globe share expertise on improving patient outcomes. For healthcare providers across the care spectrum: inpatient care, primary healthcare providers, EMS, and ongoing professional advancement through healthcare certification.
…
continue reading
Hypertrophic Cardiomyopathy (HCM) is the most common form of genetic heart disease and can affect people of any age yet is often undiagnosed. Learn more about HCM in this podcast series to discuss its impact with your patients.
…
continue reading
This podcast series for healthcare professionals offers expert insights and discussion on the prevalence of high cholesterol. Learn about improving cholesterol management with a healthy lifestyle and discuss treatment plans.
…
continue reading
This podcast series for healthcare professionals offers expert insights and discussion on pericardial disease. Recurrent pericarditis is a common complication after an initial episode of acute pericarditis, characterized by the recurrence of chest pain and signs of cardiovascular inflammation. Listen, learn, and increase your knowledge of pericardial disease.
…
continue reading
The American Heart Association’s Statements and Guidelines podcast is a podcast where we’ll discuss clinical practice guidelines and scientific statements on various cardiovascular disease and stroke topics.
…
continue reading
While patients may have different goals and preferences for treatment, which can make selecting the best hypertension management plan difficult, adherence may be increased if the plan aligns with the patient’s preferences. What approaches in shared decision-making may improve adherence? In this episode clinicians and a patient discuss changes in terminology when talking about patient compliance to the use of adherence and non-adherence. These changes are part of the larger shift to shared de ...
…
continue reading
1
Episode 20: You Wouldn’t Risk It – Pharmacologic considerations for anticoagulant therapy in Afib patients
14:35
This episode explores current guideline recommendations for anticoagulant use in Afib patients, factors that contribute to undertreatment, and common drug interactions to be considered in anticoagulated Afib patients who are being treated in other disease care settings.Por American Heart Association
…
continue reading
1
Episode 19: You Wouldn’t Risk It – Overcoming patient barriers to ensure access to anticoagulant therapy
20:14
This week's episode will take a closer look at the common barriers to anticoagulant therapy in Afib patients. We will examine strategies to support shared decision making, patient education, and navigating those crucial conversations to overcome patient refusal of guideline directed therapy.Por American Heart Association
…
continue reading
1
Episode 18: You Wouldn’t Risk It – Workflows ensuring care continuity from patient admission to EP consult
12:48
This week's episode will delve into the complex workflows within a health system and how they be a help or a hinderance to an AFib patient once they are discharge. Our guest will demonstrate effective strategies that allow collaboration both within the hospital as well as with external clinics to ensure that care management does not end at discharg…
…
continue reading
1
Episode 17: You Wouldn’t Risk It – Creating a culture of quality through education in the staffing process
22:01
This week's episode provides a roadmap for creating a culture of high-quality Afib care within a health system. We'll discuss the importance of anticoagulant therapy and Afib management education outside of the electrophysiology and cardiology teams, how this education is reflected in other care settings, and how this can be replicated.…
…
continue reading
1
AHA HCM Clinical Update: 2024 Guideline for Management of Hypertrophic Cardiomyopathy
1:05:24
1:05:24
Reproducir más Tarde
Reproducir más Tarde
Listas
Me gusta
Me gusta
1:05:24
In this On Demand video, Dr. Steve Ommen and Dr. Carolyn Ho discuss recent updates to the 2024 Guideline for the Management of Hypertrophic Cardiomyopathy (HCM). Watch now to enhance your knowledge on the importance of shared decision-making, the use of cardiac myosin inhibitors to treat symptomatic obstructive HCM, and risk stratification for atri…
…
continue reading
1
Episode 16: You Wouldn’t Risk It – Leveraging your EHR systems to improve medication education
20:39
This week's episode provides insight into the process of successfully implementing an EHR solution within a health system with the goal of improving medication education for anticoagulant therapy in Afib patients. We will team pharmacy's role, workflows, dosing, monitoring, and education tracking.Por American Heart Association
…
continue reading
The 4 F's of AFib addresses gaps and barriers to care for the diagnosed and undertreated AFib patient around four key areas of concern - Frailty, Falls, Fear or Bleeding, and Forgetfulness.Por American Heart Association
…
continue reading
The 4 F's of AFib addresses gaps and barriers to care for the diagnosed and undertreated AFib patient around four key areas of concern - Frailty, Falls, Fear or Bleeding, and Forgetfulness.Por American Heart Association
…
continue reading
The 4 F's of AFib addresses gaps and barriers to care for the diagnosed and undertreated AFib patient around four key areas of concern - Frailty, Falls, Fear or Bleeding, and Forgetfulness.Por American Heart Association
…
continue reading
The 4 F's of AFib addresses gaps and barriers to care for the diagnosed and undertreated AFib patient around four key areas of concern - Frailty, Falls, Fear or Bleeding, and Forgetfulness.Por American Heart Association
…
continue reading
This episode explores the medications involved in treating hyperlipidemia-related ASCVD from a pharmacist perspective and the common patient misconceptions surrounding these interventions. Speaker: Megan Supple, PharmD, BCACP, CPP Ambulatory Care Pharmacist Cone Health Medical Group Cardiovascular Division…
…
continue reading
This episode examines the most common patient perceived barriers to treatment and management strategies to overcome these situations in the outpatient/clinic setting. Speaker: Kevin Hwang, MD Associate Professor of Internal Medicine at McGovern Medical School Medical Director, UT General Internal Medicine clinic in the Texas Medical Center…
…
continue reading
This episode evaluates pathways to identify adults with high ASCVD risk and intervention with lipid-lowering therapy in the Emergency Department. Speaker: James Langabeer, MD Professor of Emergency Medicine Vice Chair- Population HealthPor American Heart Association
…
continue reading
This episode lays the groundwork for our understanding of ASCVD lipid management. Our guest will walk through the algorithm for treatment to guidelines as well as address the barriers, pitfalls, and potential solutions in managing care. Speaker: Dr. Murtuza Ali ,MD Professor of Clinical Medicine Program Director- Interventional Cardiology Fellowshi…
…
continue reading
Julia Zumpano, a Registered Dietician meets with Kattia to discuss her ASCVD and the effects that her diet and exercise can improve and further prevent future events.Por American Heart Association
…
continue reading
Dr. Kevin Hwang meets with a patient, Levi, who was recently discharged from the hospital after going to the E.R. with chest pain. In the E.R., they did some EKGs and blood work and diagnosed him with a heart attack. Also, they did a cardiac catheterization, where they found blockages in his arteries, ultimately putting a stent in one of them. Fina…
…
continue reading
Carolyn Dickens, a nurse practitioner that works in cardiology, speaks with Ms. Sharma who recently had a heart attack and is seeking help with making healthier choices as she learns to live with the impact of ASCVD.Por American Heart Association
…
continue reading
Our patient Rob, who has been diagnosed with ASCVD, pays a visit to Dr. Salazar to learn more about the patient health care journey he is about to embark upon.Por American Heart Association
…
continue reading
Listen as Dr. Howard Haft & Dr. Tracy Yu-Ping Wang discuss techniques on how to improve the transition of care for ASCVD patients into the outpatient setting – and how social determinants of health play a factor in treatment plans.Por American Heart Association
…
continue reading
One of the biggest challenges for newly diagnosed ASCVD patients is medication adherence. Listen as Dr. Michelle Chu, PharmD discusses how to work with patients who are struggling to adapt to their new lifestyle and the importance of integrating their care givers into the conversation. One of the biggest challenges for newly diagnosed ASCVD patient…
…
continue reading
How does the equity gap play a role in lipid management? Join us as we interview Dr. Keith Ferdinand on the importance of recognizing & addressing implicit bias in cardiovascular care, and what he is doing at Tulane university to train future physicians in this subject matter.Por American Heart Association
…
continue reading
Resistant hypertension affects twenty percent of all hypertensive patients. It is the source of much cardiovascular risk and its ultimate sequela. To this end innovative mechanisms of addressing this problem have and are being developed. One of these is renal denervation of the sympathetic system. Our guests on the podcast compare clinical studies …
…
continue reading
Managing hypertension is complex as you consider aspects of taking multiple medications, making lifestyle changes with diet and physical activity, and learning self-monitoring of blood pressure at home. As supported by guideline recommendations, team-based care among multidisciplinary healthcare professionals is important to optimize blood pressure…
…
continue reading
Weight management, physical activity, and a heart-healthy diet are key behaviors in managing blood pressure and essential to lifelong good health. What role do clinicians play in shared decision making discussions with hypertensive patients around daily lifestyle decisions. What steps can clinicians take in providing guideline informed hypertension…
…
continue reading
Home blood pressure monitoring is informative but inaccessible for some outside of strengthened clinical support. Current guidelines comprehensively address how to define, measure, and treat high blood pressure, and yet hypertension management in special patient populations has not been systematically addressed. Listen and learn how clinicians can …
…
continue reading
While patients may have different goals and preferences for treatment, which can make selecting the best hypertension management plan difficult, adherence may be increased if the plan aligns with the patient’s preferences. What approaches in shared decision-making may improve adherence? In this episode clinicians and a patient discuss changes in te…
…
continue reading
Dr. Salim Virani, professor of medicine at Aga Khan University and cardiologist at Texas Heart Institute, and Dr. Kristin Newby, professor of medicine at the Duke University School of Medicine, served together as co-chairs for the 2023 American Heart Association and American College of Cardiology Guideline for Chronic Coronary Disease. These guidel…
…
continue reading
Renal denervation in the management of hypertension in adults has yet to be approved in the US, however, it is under FDA review. This procedure may be useful for adults with uncontrolled or resistant hypertension (triple drug therapy, one of which is a diuretic) and may be an option for patients unable to tolerate long-term medications at the neces…
…
continue reading
Complicated pericarditis can occur in 15-30% of patients after an episode of acute pericarditis. This podcast will review the initial diagnosis, clinical evaluation, and treatment of the long-term complications of recurrent pericarditis. Learn more about the risk factors and precautions to take to prevent or reduce development of complications from…
…
continue reading
1
Recurrent Pericarditis in Systemic Autoinflammatory and Autoimmune Disease – Clinical Recognition and Management
38:40
While healthcare providers may initiate corticosteroids in patients with recurrent pericarditis, patients with autoimmune rheumatic disease and cardiac involvement should also be managed in collaboration with a rheumatologist particularly. In this podcast, experts explore in more detail the diagnosis and clinical features of monogenic autoinflammat…
…
continue reading
In this podcast learn more about the role interleukin-1 (IL-1) plays in the pathophysiology of pericarditis. Listen Now!Por American Heart Association
…
continue reading
It is estimated that 1 in every 500 adults living in the U.S. have HCM, but a large percentage of patients are undiagnosed. Listen to this podcast to gain insight into hypertrophic cardiomyopathy (HCM) screening and what it means to your patients.Por American Heart Association
…
continue reading
Listen as Dr. Howard Haft & Dr. Tracy Yu-Ping Wang discuss techniques on how to improve the transition of care for ASCVD patients into the outpatient setting – and how social determinants of health play a factor in treatment plans.
…
continue reading
One of the biggest challenges for newly diagnosed ASCVD patients is medication adherence. Listen as Dr. Michelle Chu, PharmD discusses how to work with patients who are struggling to adapt to their new lifestyle and the importance of integrating their care givers into the conversation.
…
continue reading
How does the equity gap play a role in lipid management? Join us as we interview Dr. Keith Ferdinand on the importance of recognizing & addressing implicit bias in cardiovascular care, and what he is doing at Tulane University to train future physicians in this subject matter.
…
continue reading
Making the correct of hypertrophic cardiomyopathy (HCM) is critical in being able to initiate early surveillance and therapy to improve patient outcomes. In this podcast focusing on pharmacologic treatment options, learn more about completed and ongoing myosin inhibitor clinical trials.Por American Heart Association
…
continue reading
Listen to this podcast to better understand the triggers causing recurrent episodes of pericarditis. Experts discuss how to assess those triggers to direct optimal therapy.Por American Heart Association
…
continue reading
Accurate diagnosis of Hypertrophic Cardiomyopathy (HCM) is critical. HCM is a chronic and progressive disease putting patients at risk of serious complications and co-morbidities. Early and correct detection may help reduce some of the consequences of HCM and improve outcomes. In this podcast, learn more about how to distinguish phenocopies from HC…
…
continue reading
In this podcast, Drs. Forouzandeh and Lin and Katherine Di Palo discuss initial management of recurrent pericarditis. Learn how to distinguish acute pericarditis from recurrent pericarditis. They will also explore diagnostic criteria and initial pharmacotherapy for recurrent pericarditis. Listen now to get more insight on care delivery strategies t…
…
continue reading
1
The Role of Echocardiography in the Diagnosis and Management of Patients with Hypertrophic Cardiomyopathy
28:54
Diagnosis of hypertrophic cardiomyopathy is typically done by echocardiogram to assess the thickness of the heart muscle and observe blood flow in and out of the heart. In this podcast, learn more about how echocardiography is used in the diagnosis, screening, and management of HCM.Por American Heart Association
…
continue reading
Hypertrophic cardiomyopathy (HCM) is the most common form of inherited heart disease and can affect people of any age. In this episode, learn what causes hypertrophic cardiomyopathy in children and the clinical and genetic screening needed to diagnosis HCM.Por American Heart Association
…
continue reading
In this podcast, Drs. Tevfik Ismail, Antonio Brucato, and Robert Barcelona will focus on the treatment of acute pericarditis and review the relevant clinical pharmacology of the agents used. appropriate pharmacologic therapies. Learn more on the use of drugs that are off-label drug therapy for acute pericarditis in the United States and other juris…
…
continue reading
Although the cardiovascular and overall health benefits of regular activity are well-established, recommendations for recreational exercise and competitive sports participation for patients with HCM have been challenging. Listen to this podcast as Drs. Abraham, Day, and Martinez along with Brian Metz discuss exercising with HCM and the importance o…
…
continue reading
Learn more in this podcast on the causes, complications and treatments of acute pericarditis and explore how to prevent an initial episode of acute pericarditis from evolving into recurrent pericarditis.Por American Heart Association
…
continue reading
Pericarditis is inflammation of the fibroelastic pericardial sac. Acute pericarditis has been observed in ≈0.1% of hospitalized patients and 5% of patients admitted to the emergency department with a diagnosis of noncardiac chest pain. In this podcast, learn the clinical features of Acute Pericarditis.…
…
continue reading
Hypertrophic cardiomyopathy (HCM) is the most common form of genetic heart disease and can affect people of any age, yet it often goes undiagnosed. Genetic testing and counseling plays an important role in the diagnosis and management of HCM in patients in families. Learn more about genetic testing and counseling, and its impact on the patient’s fa…
…
continue reading
People with HCM are at increased risk for developing arrythmias such as atrial fibrillation, suffering from stroke and even sudden cardiac arrest. People with HCM face a risk of death more than 3 times greater than the average person of the same age without HCM. Learn more about the complex relation between atrial fibrillation and hypertrophic card…
…
continue reading
Surgical and interventional options such as surgical myectomy or alcohol septal ablation may help those with obstructive Hypertrophic Cardiomyopathy (HCM) to reduce or remove the obstruction. A similar option is unavailable to those with non-obstructive HCM. Heart transplants are considered as a last resort for HCM patients who progress to end stag…
…
continue reading
Statins are the cornerstone of lipid lowering drugs. Listen as Drs. Natarajan, Michos, and Kara discuss the role of statins for cardiovascular disease prevention as well as new incorporation of some non-statin cholesterol-lowering medications in 2018 AHA/ACC Cholesterol Guidelines.Por American Heart Association
…
continue reading
A deep dive discussion between Drs. Pradeep Natarajan, Ron Blankstein and Khurram Nasir in assessment of Coronary artery calcium (CAC) to help guide prognosis and management. In this podcast learn the role of CAC score.Por American Heart Association
…
continue reading